Press Release

<< Back
View printer-friendly version
BD to Present at the Raymond James 39th Annual Institutional Investors Conference

FRANKLIN LAKES, N.J., Feb. 28, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Raymond James 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, at 2:15 p.m. EST.

Live webcasts of BD's presentations can be accessed from the BD corporate website at and will be available for replay through Tuesday, March 13, 2018. 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit

Kristen Cardillo, Communications – 201-847-5657
Monique N. Dolecki, Investor Relations – 201-847-5378


Cision View original content:

SOURCE BD (Becton, Dickinson and Company)